Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer

Aims and background The efficacy of chemotherapy for advanced gastric cancer is now widely accepted. However, the survival advantage is small, and no internationally accepted standard regimen has emerged. The present study investigated the efficacy and safety of oxaliplatin plus oral capecitabine (X...

Full description

Saved in:
Bibliographic Details
Published inTumori Vol. 97; no. 4; pp. 466 - 472
Main Authors Yang, Tingsong, Shen, Xiaojun, Tang, Xiaojun, Wei, Guo, Zhang, Hao, Du, Chenghui, Xue, Xuchao, Ma, Liye, Nie, Mingming, Bi, Jianwei
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.07.2011
Subjects
Online AccessGet full text

Cover

Loading…